SecBot SecBot
144 ·Filed Jun 26, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 6/10
Horizondays Processed4mo ago SEC0001950047-26-006565
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The CEO's sustained selling over the past month, including this new Form 144, is a strong negative signal. Despite bullish analyst consensus, the insider's consistent unloading of shares suggests a lack of confidence in near-term valuation or upcoming catalysts. Traders should monitor for any negative news or guidance changes and consider reducing positions or hedging.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$65.97
T+0 close · Jun 26, 2026 · via day close
Latest settled
−18.27%
T+60 · $53.92
Vs SPY
−22.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $65.97entry
  2. T+1 · 5mo ago +2.32%α +1.54% · $67.50
  3. T+5 · 4mo ago −5.55%α −6.94% · $62.31
  4. T+20 · 4mo ago −17.92%α −17.64% · $54.15
  5. T+60 · 8w ago −18.27%α −22.65% · $53.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Dennis Mulroy filed a Form 144 on June 26, 2026, indicating intent to sell 10,000 shares of AnaptysBio common stock, valued at approximately $608,183. This filing is part of a sustained selling pattern: Mulroy has sold over 300,000 shares in the past month, totaling roughly $18 million, with the latest tranche sourced from a stock option exercise.

Key Facts

  • CEO Dennis Mulroy filed Form 144 to sell 10,000 shares valued at ~$608,183.
  • The proposed sale follows a stock option exercise on June 26, 2026.
  • Mulroy has sold over 300,000 shares since May 15, 2026, totaling approximately $18 million.
  • Prior sales include: 35,000 shares on June 11 ($1.85M), 22,491 on June 5 ($1.15M), and 20,000 on June 3 ($1.02M).
  • The company has a market cap of $1.9B and 94% analyst bullish consensus.

Financial Impact

CEO selling ~$608K in a single proposed transaction, part of a ~$18M selling wave over the past month.

dilutioninsider ownership

Risk Factors

  • CEO selling may signal deteriorating fundamentals or upcoming negative catalysts.
  • Continued insider selling could pressure the stock price and erode investor confidence.
  • The selling wave may indicate that the CEO believes the stock is fully valued or overvalued.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006565
Document: 0001950047-26-006565-index.html0001950047-26-006565
Document: 0001950047-26-006565.txt0001950047-26-006565

Track record

28 reports on ANAB

Performance horizon

10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Viewing Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026